Wednesday, February 10, 2010, 1:40PM AEST - The Australian Stockmarket closes in 2 hours and 25 minutes.
To create a watchlist or portfolio of shares, Register

Gilead Sciences Inc. (GILD)

 8:00AM AEST: 46.30 USD  Up 0.21 (0.46%)  
 MORE ON GILD 
Quotes
HereSummary
Charts
Technical Analysis
News & Info
Company
Analyst Coverage
Ownership
Financials
 Gilead Sciences, Inc. (NasdaqNM:GILD) Delayed quote dataEdit
Last Trade:46.30 USD
Trade Time: 8:00AM AEST
Change:Up 0.21 (0.46%)
Prev Close:46.09
Open:46.61
Bid:46.16 x 200
Ask:46.66 x 300
1y Target Est:54.57
Day's Range:46.05 - 47.00
52wk Range:40.62 - 51.85
Volume:9,495,990
Avg Vol (3m):8,522,300
Market Cap:41.66B
P/E (ttm):17.90
EPS (ttm):2.59
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
 Add GILD to Portfolio   Download Data

 HEADLINES 
•Cramer's Lightning Round - I Like Nike (2/8/10)
at Seeking Alpha (Tue 8:49PM)
•Lightning Round: Nike, Visa, Gilead Science and More
at CNBC (Tue 3:28PM)
•'Mad Money Lightning Round': Visa Rocks
at TheStreet.com (Tue 11:33AM)
•Cramer's 'Mad Money' Recap: The Lure of Semiconductor Stocks (Final)
at TheStreet.com (Tue 11:24AM)
•[video] Options Action
at CNBC (Tue 9:34AM)
•[$$] Biotech ETFs Are Looking Healthy
at RealMoney by TheStreet.com (Tue 8:50AM)
•Director William Furman Buys $2.1M Worth of Schnitzer Steel
TheStreet.com (Tue 2:58AM)
•4 Winning Biotechs For Your Portfolio: Senior Analyst
at CNBC (Tue 2:34AM)
•Traders Send Select Stem Cell Shares Soaring
Indie Research (Tue 2:28AM)
•Is Biotech Back?
CNBC (Tue 1:31AM)
•[video] Is Biotech Back?
at CNBC (Tue 12:08AM)
•Micrus Endovascular (MEND): Zacks Rank Buy
Zacks.com (Mon, Feb 8)
•Bears Claw Retail ETF With Options
at Forbes.com (Sat, Feb 6)
More Headlines for GILD...
 ANALYST 
EPS Est (next year) (Dec-09) :2.77
EPS Est (in 2 years) (Dec-10) :3.11
Avg Rec (current)*:1.9
PEG Ratio:1.13
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Gilead Sciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for the treatment of life-threatening infectious diseases.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
•Latest News•7 Indices